YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
Bagoodex’s former site now directs visitors to Sigma’s hosted AI chat service. Isomorphic Labs is an AI drug-design company developing therapeutics through internal programs and pharmaceutical partnerships. Ratings are subjective editorial opinions for each product’s stated purpose, not measured benchmarks.
Bagoodex’s former site now directs visitors to Sigma’s hosted AI chat service. The current destination is a browser chat application. Historical Bagoodex search claims should not be assumed to describe every capability of Sigma Chat.
Isomorphic Labs is an AI drug-design company developing therapeutics through internal programs and pharmaceutical partnerships. Its predictive and generative models support molecular design and in-silico experiments for small molecules and biologics. Scientists must select, test and validate candidates; a designed molecule is not an approved medicine.
These scores express our judgement of the cited product facts. They are not measured performance benchmarks. Each product is assessed for its stated purpose; a higher score does not make different workflows interchangeable.
Evidence gaps lower confidence and affect the relevant judgement. Unknown pricing does not mean free access. Research prototypes and retired products retain their historical scope, with adoption ratings reflecting current access.
Ratings assessed: 2026-11-07. Source verification dates may differ.
Documented capability: How useful and complete is the documented workflow for the product's stated purpose?
Ease of adoption: Can the intended user obtain and set up a usable product today?
Value and cost clarity: How attractive and understandable is the cost model for the documented use?
Integration options: How useful and extensible are the verified user-facing connections for the intended workflow?
Bagoodex: 5/10
Evidence confidence: medium
The current destination is a browser chat application. Historical Bagoodex search claims should not be assumed to describe every capability of Sigma Chat.
Isomorphic Labs: 7/10
Evidence confidence: high
Its predictive and generative models support molecular design and in-silico experiments for small molecules and biologics. Scientists must select, test and validate candidates; a designed molecule is not an approved medicine.
The scores judge completeness for each stated purpose; different workflows are not interchangeable.
Bagoodex: 7/10
Evidence confidence: medium
The redirect provides a live browser entry point, but account access and the selected chat offer determine the usable features.
Isomorphic Labs: 3/10
Evidence confidence: high
This is a specialist research organization and partnership route, not a self-service research assistant that an individual can subscribe to.
Access, setup and human responsibilities matter alongside features.
Bagoodex: 4/10
Evidence confidence: medium
Current account terms need checking at the Sigma destination; old Bagoodex pricing is not a reliable purchase guide.
Isomorphic Labs: 3/10
Evidence confidence: high
Commercial collaborations have negotiated terms. There is no public per-seat software offer to use as a purchasing comparison.
Compare the full cost of your intended workflow, including external services and implementation.
Bagoodex: 2/10
Evidence confidence: medium
A hosted chat interface is established, but a public automation API or broad native connector set is not established for this destination.
Isomorphic Labs: 3/10
Evidence confidence: high
Pharmaceutical partnerships are research collaborations, not software connectors. A public general-purpose drug-design API is not part of the published offer.
Choose the connections your workflow needs, rather than counting partner logos.
Follow the current Sigma destination if you want general chat, and check its current account terms. It is not a medical or drug-design system.
Consider Isomorphic Labs in the context of pharmaceutical research partnerships, not as an immediately available desktop or web agent.
YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
Give businesses AI teams that own ongoing roles. Set your pricing, delegate routine coordination and build a recurring service.